Metraipolis › archive › dc_44b92daf24be

Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: post hoc secondary analysis of the CEREHETIS trial — Europe PMC PMID:41640685

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41640685
DOI
10.3389/fphar.2025.1725255
License (as archived)
solo-consultazione
Archived
2026-11-07T00:14:53.695Z
SHA-256 of the archived text
db66075321e885d20256a03357459e7b8fe69d7e75c9d472b8b64b097d2290a9
Stable URL of this page
https://metraipolis.com/documento/dc_44b92daf24be

How to cite

Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: post hoc secondary analysis of the CEREHETIS trial — Europe PMC PMID:41640685 — Europe PMC (en), https://europepmc.org/article/MED/41640685 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44b92daf24be (Metraipolis archive dc_44b92daf24be, sha256 db66075321e885d20256a03357459e7b8fe69d7e75c9d472b8b64b097d2290a9)
BibTeX
@misc{dc44b92daf24be,
  title = {Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: post hoc secondary analysis of the CEREHETIS trial — Europe PMC PMID:41640685},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41640685},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44b92daf24be; sha256 db66075321e885d20256a03357459e7b8fe69d7e75c9d472b8b64b097d2290a9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41640685. Agents can read the archived copy with the MCP tool read_document.